title: The effect of different rituximab-containing chemotherapy strategies on hepatitis C viremia.
authors.affiliation: a Department of Infectious Diseases , Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
authors.forename: Parag
authors.initials: P
authors.lastname: Mahale
authors.affiliation: b Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
authors.forename: Francesco
authors.initials: F
authors.lastname: Turturro
authors.affiliation: b Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
authors.forename: Jorge E
authors.initials: JE
authors.lastname: Romaguera
authors.affiliation: b Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
authors.forename: Nathan
authors.initials: N
authors.lastname: Fowler
authors.affiliation: a Department of Infectious Diseases , Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
authors.forename: Harrys A
authors.initials: HA
authors.lastname: Torres
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D016174:Hepacivirus / Q000187:drug effects* / Q000502:physiology*; D006526:Hepatitis C / Q000150:complications* / Q000821:virology*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications* / Q000188:drug therapy; D000069283:Rituximab / Q000008:administration & dosage / Q000009:adverse effects*; D019562:Viral Load; D014766:Viremia; D014775:Virus Activation / Q000187:drug effects
chemical_list: D000069283:Rituximab